[1] Carey EJ,Ali AH,Lindor KD.Primary biliary cirrhosis, Lancet,2015,386:1565-1575.
[2] Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. Hepatol,2012,56:1181-1188.
[3] Griffiths L,Dyson JK Jones DE.The new epidemiology of primary biliary cirrhosis.Semin Liver,2014,34:318-328.
[4] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和诊疗共识(2015).中华肝脏病杂志, 2016,24:5-13.
[5] Desmet V. Pathology of small duct cholangiopathies. AASLD 1996. Postgraduate Course, 1996: 91-97.
[6] Liu HY Liu YF,Wang LX,et al.Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China.BMC Gastroenterol,2010,3:100.
[7] 何丽芬,赖伊杰,赖力英,等.原发性胆汁性肝硬化的临床特点.中南大学学报,2015,40:1333-1339.
[8] 罗莉丽,周璐,张洁,等.血清自身抗体在诊断抗线粒体抗体阴性的原发性胆汁性肝硬化中的价值.中华消化杂志,2015,35:86-89.
[9] Yamagiwa S,Kamjmura H,Takamura M,et al.Autoantibodies in primary biliary cirrhosis:recentprogress in research on the pathogenetic and clinical significance.World J Gastroentero,2014,20:2606-2612.
[10] Muratori P,Muratori L,Ferrari R,et al.Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis..Am J gastroenterol,2003,98:431-437.
[11] Duarte-Rey C,Bogdanos D,Yang CY,et al.Primary biliary cirrhosis and the nuclear pore complex.Autoimmun Rev,2012,11:898-902.
[12] 唐映梅,包维民,尤丽英,等.原发性胆汁性肝硬化患者血清抗GP210和抗SP100检测的临床意义.实用肝脏病杂志,2011,14:132-134.
[13] Jiang XH,Zhong RQ,Yu QI et al.Construction and expression of ahumanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis.World J Gastroenterol,2003,9:1352-1355.
[14] Achenza MI,Meda F,Brunetta E,et al.Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.Expert Rev Gastroenterol,2012,6:717-729. |
